SNYNF:OTCMKTS
Sanofi SA
$ 78.55
arrow_upward
+0.49%(+0.38) 1D
10-р сарын 15, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNYNF...
Open
$ 78.55
High
$ 78.55
Low
$ 78.55
Mkt. cap
98.14 тэрбум
Avg. vol.
5.47 мян
Volume
482.00
52-wk high
$ 106.34
52-wk low
$ 76.76
Beta
0.32
Shares outstanding
1.21 тэрбум
No. of employees
75 мян
Open
$ 78.55
High
$ 78.55
Low
$ 78.55
Mkt. cap
98.14 тэрбум
Avg. vol.
5.47 мян
Volume
482.00
52-wk high
$ 106.34
52-wk low
$ 76.76
Beta
0.32
Shares outstanding
1.21 тэрбум
No. of employees
75 мян
News stories
From web sources and news partners
Utah Business
·
6 цагийн өмнө
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate
Yahoo Finance
·
9 цагийн өмнө
Sanofi (ENXTPA:SAN) Stock Looks Reasonable After Its Antibody Deal
Quiver Quantitative
·
11 цагийн өмнө
Recursion Pharmaceuticals Jumps After Sanofi Milestone, Clinical Updates, and $200 Million Financing
Investing.com Canada
·
16 цагийн өмнө
Recursion receives $10M milestone from Sanofi collaboration By Investing.com
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74.8 мян
Founded1973
HeadquartersПарис, Иль-де-Франс, Франц
SectorPharmaceutical industry
Websitesanofi.com